Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Targeting Immunity in the Treatment of PAH: The Rituximab SSc-PAH Trial

Mark Nicolls


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Conference: Keystone Symposium: Pulmonary Vascular Disease and RV Dysfunction: Current Concepts and Future Therapies

Release Date: 10.23.2012

This presentation was presented at the 2012 Keystone Symposium: "Pulmonary Vascular Disease and Right Ventricular Dysfunction: Current Concepts and Future Therapies".

 

 

In this recording from the 2012 Keystone Symposium on "Pulmonary Vascular Disease and Right Ventricular Dysfunction: Current Concepts and Future Therapies," Dr. Mark Nicolls discusses the Ruximab SSC-PAH trial which is currently taking place in study sites around the U.S.

 

View Recording